Biological Therapy Analysis & Statistics, November 2013 (p7)

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: stem cell, cell therapy, tissue engineering, more »

181-210 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Stem Cell Sciences Plc (STEM) - Strategic SWOT Analysis Review

Stem Cell Sciences Plc (STEM) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Stem Cell Sciences Plc provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased ...

  • Industries : Biological Therapy
Physician Views: Oncologist reaction to Roche's Gazyva - US approval and new late-stage data versus Rituxan

Physician Views: Oncologist reaction to Roche's Gazyva - US approval and new late-stage data versus Rituxan

  • $ 645
  • Industry report
  • November 2013
  • by Firstword Pharma

Scope Roche's efforts to enhance its dominance of the haematological cancer market received notable momentum last week when the company gained FDA approval for Gazyva as a first-line treatment for chronic ...

  • Industries : Biological Therapy
  • Countries : United States
Bone Regeneration - Pipeline Review, H2 2013

Bone Regeneration - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Bone Regeneration - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Biological Therapy
  • Countries : World
Competitor Analysis: CD19-Targeted Therapeutics

Competitor Analysis: CD19-Targeted Therapeutics

  • $ 264
  • Industry report
  • October 2013
  • by La Merie Publishing

Renewed interest in CD19 as target for antibody and T-cell Therapeutics The human CD19 antigen is a 95 kd transmembrane glycoprotein. It is specifically expressed in normal and neoplastic B cells, ...

  • Industries : Biological Therapy
Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017

Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017

  • $ 3 450
  • Industry report
  • October 2013
  • by BioInformant Worldwide, L.L.C.

EXECUTIVE SUMMARY Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Categorized by ...

  • Industries : Biological Therapy
  • Countries : United States
RNAi Technologies and Global Markets

RNAi Technologies and Global Markets

  • $ 6 650
  • Industry report
  • October 2013
  • by BCC Research

STUDY GOALS AND OBJECTIVES This BCC Research report, RNAi: Technologies and Global Markets, provides an overview of the current state of the RNA interference (RNAi) market, focusing specifically on RNAi ...

  • Industries : Biological Therapy
  • Countries : World
Global MicroRNA Market 2012-2016

Global MicroRNA Market 2012-2016

  • $ 2 500
  • Industry report
  • September 2013
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global MicroRNA market to grow at a CAGR of 17.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in microRNA ...

  • Industries : Biological Therapy
  • Countries : World
Biocompatibles International Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Biocompatibles International Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2013
  • by Global Data

Summary Biocompatibles International Ltd. (Biocompatibles) is a medical technology company, engaged in the development of products used for the treatment of cancer and benign tumors. The company is divided ...

  • Industries : Biological Therapy
Reliance Life Sciences Pvt. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Reliance Life Sciences Pvt. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2013
  • by Global Data

Summary Reliance Life Sciences Pvt. Ltd. (Reliance Life Sciences) is a diversified and integrated biotechnology initiative company of the Reliance Group in India. Its activities include research, development ...

  • Industries : Biological Therapy
  • Countries : India
Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2013

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2013

  • $ 2 000
  • Industry report
  • August 2013
  • by Global Markets Direct

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2013', provides an overview of the indication's ...

  • Industries : Biological Therapy
  • Countries : United States, World
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)

The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)

  • $ 3 995
  • Industry report
  • August 2013
  • by Kalorama Information

Circulating tumor cells (CTCs) are believed to detach from primary or secondary tumors and enter the bloodstream, traveling to distant organs and forming new tumors. These cells that leave the primary ...

  • Industries : Biological Therapy
  • Countries : World
Operation on the Hemic & Lymphatic System in Europe - Surgical Procedure Volumes - 2013

Operation on the Hemic & Lymphatic System in Europe - Surgical Procedure Volumes - 2013

  • $ 215
  • Industry report
  • August 2013
  • by Quomeda Ltd

Operation on the Hemic & Lymphatic System in Europe - Surgical Procedure Volumes - 2013 is a report adaptation of Quomeda's most recent Surgical Procedures Volumes Database and includes procedure numbers ...

  • Industries : Biological Therapy
  • Countries : Europe
Stem Cell Technologies: World Market Outlook 2013-2023

Stem Cell Technologies: World Market Outlook 2013-2023

  • $ 3 013
  • Industry report
  • August 2013
  • by Visiongain

Report Details Stem cells: why that market can expand - you discover its sales potential What are the commercial prospects for stem cells? Visiongain's updated report predicts revenues to 2023. There you ...

  • Industries : Biological Therapy
  • Countries : World, United States
Stem Cell Markets

Stem Cell Markets

  • $ 3 400
  • Industry report
  • August 2013
  • by TriMark Publications

A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. ...

  • Industries : Biological Therapy
  • Countries : World, United States
Advances in Tissue Engineering and Organ Regeneration (Technical Insights)

Advances in Tissue Engineering and Organ Regeneration (Technical Insights)

  • $ 6 500
  • Industry report
  • August 2013
  • by Frost & Sullivan

State-of-the-Art Technology for Artificial Organ Implant Tissue engineering, which is now being categorized as a form of regenerative medicine, can be defined as biomedical engineering to reconstruct, ...

  • Industries : Biological Therapy
B-Cell Leukemia - Pipeline Review, H2 2013

B-Cell Leukemia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

B-Cell Leukemia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'B-Cell Leukemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World
uniQure BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile

uniQure BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary uniQure BV (uniQure) develops human gene based therapies. The company's technologies and capacities include platform vector technology, platform manufacturing technology, clinical development and ...

  • Industries : Biological Therapy
  • Countries : United States
Applied Stemcell, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Applied Stemcell, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Applied Stemcell, Inc. is engaged in developing and commercializing standardized solutions and tools for stem cell research. The company offers a wide range of quality stem cell culture products ...

  • Industries : Biological Therapy
Glycosan BioSystems, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glycosan BioSystems, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Glycosan BioSystems, Inc. is a pharmaceutical and healthcare company. The company is engaged in producing pharmaceutical-grade hydrogels for 3D cell culture, stem cell culture, tissue engineering ...

  • Industries : Biological Therapy
iPS Academia Japan, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

iPS Academia Japan, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary iPS Academia Japan, Inc is a research and development company manages patents and other intellectual property related to methods of creating iPS cells, and licenses the right to use these patented ...

  • Industries : Biological Therapy
  • Countries : Japan
Histostem, Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Histostem, Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Histostem, Co., Ltd. is a biotechnology company well known for its development of the technology of mixing cord blood for stemcell transplantation. The company is engaged in cell therapy research, ...

  • Industries : Biological Therapy
Kite Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kite Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Kite Pharma, Inc. (Kite Pharma) is a development stage biotechnology company. It undertakes the development of innovative targeted immunotherapies for the treatment of cancer. The company focuses ...

  • Industries : Biological Therapy
  • Countries : United States
Antisense Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Antisense Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Antisense Pharma GmbH (Antisense Pharma) is a biotechnology company. The company conducts research and develops innovative pharmaceutical products. The company focuses on the development of antisense ...

  • Industries : Biological Therapy
Genetrix SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genetrix SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Genetrix SL (Genetrix) is a biotechnology company. It manufactures and markets product offering biotechnological solutions. The company consists of technology development companies including Sygnis, ...

  • Industries : Biological Therapy
RNL BIO Co., Ltd. (CBTEQ.PK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

RNL BIO Co., Ltd. (CBTEQ.PK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary RNL BIO Co., Ltd. (RNL BIO) is a biotechnology company, based in Republic of Korea. The company develops, manufactures and markets stem cell therapy products. It offers products and services in ...

  • Industries : Biological Therapy
  • Countries : South Korea
Gamida Cell Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Gamida Cell Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Gamida Cell Ltd. (Gamida) is a health care company. The company is into development of therapeutic products. Its product StemEx is used for the treatment of leukemia, lymphoma, krabbe disease, ...

  • Industries : Biological Therapy
ES Cell International Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ES Cell International Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary ES Cell International Pte, Ltd. (ESI) is a regenerative medicine company, based in Singapore. The company develops human embryonic stem cell technologies for research and commercial applications. ...

  • Industries : Biological Therapy
  • Countries : Singapore
Verastem, Inc. (VSTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Verastem, Inc. (VSTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Verastem, Inc. (Verastem) is a clinical-stage biopharmaceutical company. It discovers and develops drugs for the treatment of cancer by the targeted killing of cancer stem cells. The company develops ...

  • Industries : Biological Therapy
  • Countries : United States
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Stem Cell Innovations, Inc. (SCLL)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Stem Cell Innovations, Inc. (SCLL)

  • $ 250
  • Company report
  • July 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Bionet Corp. (1784) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bionet Corp. (1784) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary BIONET Corp. (BIONET) is a pharmaceutical service provider. The company provides cord blood private banking service in Taiwan. BIONET's products include cord blood, mesenchymal stem cells, dental ...

  • Industries : Biological Therapy
  • Countries : Taiwan

33 Companies

Read our Company Profiles

Bioheart Inc.

United States

StemCells Inc.

United States

GlaxoSmithKline P.L.C.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.